Providence, RI – A leading division at Brown University Health is at the forefront of advancements in nuclear medicine, molecular imaging, and theranostics, offering a comprehensive suite of diagnostic and therapeutic procedures. The Division of Nuclear Medicine, Molecular Imaging and Theranostics at The Warren Alpert Medical School and Brown University Health is actively involved in both patient care and cutting-edge research, impacting the treatment of a wide range of conditions from cancer to neurological and cardiac diseases.
Nuclear medicine utilizes small amounts of radioactive materials, known as radiopharmaceuticals, to diagnose and treat diseases. The division performs a full range of these procedures, with all diagnostic interpretations centralized at Rhode Island Hospital, while therapeutic procedures are conducted at both Rhode Island Hospital and The Miriam Hospital. This collaborative approach ensures patients across the region have access to specialized care. The increasing sophistication of The Miriam Hospital, recently ranked first among Rhode Island Hospitals by U.S. News & World Report for 2025-2026, plays a crucial role in delivering these advanced treatments.
Expanding Capabilities in PET/CT Imaging
A particularly busy area within the division is the PET/CT (Positron Emission Tomography/Computed Tomography) service. This technology combines anatomical and functional imaging, providing detailed insights into disease processes. The division handles a substantial volume of oncologic PET/CT scans, but also performs numerous studies focused on neurological and cardiac conditions. This versatility allows for a comprehensive assessment of patient health. Nuclear Cardiology studies, utilizing both SPECT (Single-Photon Emission Computed Tomography) and PET technologies, are a collaborative effort between the Division of Nuclear Medicine and the Division of Cardiology, maximizing educational opportunities and patient outcomes.
The division currently operates four SPECT/CT cameras across Rhode Island Hospital and The Miriam Hospital, enabling a broad spectrum of general diagnostic nuclear medicine studies. These studies utilize all FDA-approved radiotracers, ensuring adherence to the highest safety and efficacy standards. Brown University Health is also investing in modernization, with a $125 million renovation underway at The Miriam Hospital, which will modernize the emergency department and increase inpatient capacity.
Therapeutic Nuclear Medicine and Multidisciplinary Collaboration
Beyond diagnostics, the division provides a full range of therapeutic nuclear medicine services. These treatments target specific diseases at a cellular level, offering potentially life-saving options for patients. Faculty members actively participate in multidisciplinary tumor boards, including regular attendance at thoracic and endocrine tumor boards, ensuring a collaborative and comprehensive approach to cancer care. This integration of expertise allows for the development of personalized treatment plans tailored to each patient’s unique needs.
Research Driving Innovation in Nuclear Medicine
Research is a cornerstone of the division’s mission. Current research topics include the exploration of fresh oncologic therapeutic radiopharmaceuticals, the development of novel brain PET agents for improved diagnosis of cognitive decline, and the scintigraphic management of patients with suspected infection. One faculty member currently leads the Nuclear Medicine Commission at the American College of Radiology and spearheads nuclear medicine education at the ACR education center, demonstrating a commitment to advancing the field nationally. All faculty members are actively involved in various national societies related to nuclear medicine, fostering collaboration and knowledge sharing.
The division’s commitment to research and education ensures that patients benefit from the latest advancements in nuclear medicine. The ongoing development of new radiopharmaceuticals and imaging techniques promises to further enhance diagnostic accuracy and therapeutic effectiveness. The collaborative environment between Brown University Health and The Warren Alpert Medical School fosters a culture of innovation and continuous improvement.
Looking ahead, the division will continue to expand its research efforts and refine its clinical protocols, solidifying its position as a leader in nuclear medicine, molecular imaging, and theranostics. The ongoing renovation at The Miriam Hospital will further enhance the division’s capabilities and allow it to serve an even greater number of patients in Rhode Island and southern New England.
Share your thoughts on these advancements in the comments below.
Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
